ALDERAAN BIOTECHNOLOGY
Alderaan Biotechnology is a Biotechnology company develops antibodies targeting new and original targets in immuno-oncology, expressed by NK cells in particular.
ALDERAAN BIOTECHNOLOGY
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.alderaan-biotechnology.com
Total Employee:
1+
Status:
Active
Total Funding:
20 M EUR
Technology used in webpage:
OVH
Similar Organizations
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Neomorph
Neomorph is a biotechnology company.
Current Employees Featured
Founder
Investors List
AdBio partners
AdBio partners investment in Series A - Alderaan Biotechnology
Medicxi
Medicxi investment in Series A - Alderaan Biotechnology
AdBio partners
AdBio partners investment in Seed Round - Alderaan Biotechnology
Official Site Inspections
http://www.alderaan-biotechnology.com
Unable to get host informations!!!
More informations about "Alderaan Biotechnology"
Alderaan Biotechnology - Funding, Financials, Valuation & Investors
Alderaan is a biotechnology company. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. ... How much funding has this organization raised over …See details»
ALDERAAN BIOTECHNOLOGY - Societe.com
ALDERAAN BIOTECHNOLOGY, société par actions simplifiée, au capital social de 47118,00 EURO, dont le siège social est situé au 4 RUE THENARD, 75005 PARIS, immatriculée au …See details»
Alderaan Biotechnology - LinkedIn
Alderaan Biotechnology | 1,208 followers on LinkedIn. A preclinical stage biotech company developing novel therapies to treat cancer by targeting cells from the immune system | …See details»
ALDERAAN BIOTECHNOLOGY Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ALDERAAN BIOTECHNOLOGY of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & …See details»
Alderaan Biotechnology - PitchBook
Alderaan Biotechnology General Information Description. Developer of a monoclonal antibody designed to offer treatment for cancer. The company's antibodies help to deplete regulatory T (Treg) cells in cancer and to boost …See details»
Alderaan Biotechnology - The Org
Alderaan Biotechnology is a Biotechnology company develops antibodies targeting new and original targets in immuno-oncology, expressed by NK cells in particular. Industries. …See details»
Alderaan Biotechnology
About: Founded in 2017 and headquartered in Paris, France, Alderaan Biotechnology works with world-class teams in the fields of immunomodulation and immunotherapy of cancer focusing …See details»
Alderaan biotechnology - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Société ALDERAAN BIOTECHNOLOGY : Chiffre d'affaires ... - Pappers
6 days ago Les déclarations de comptes de ALDERAAN BIOTECHNOLOGY nous permettent de déduire que son chiffre d'affaires était inférieur à 700 000 € ou que son bilan était inférieur …See details»
Alderaan Biotechnology - Tech Stack, Apps, Patents & Trademarks
Organization. Alderaan Biotechnology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. About. …See details»
Alderaan Biotechnology - EU-Startups
ALDERAAN BIOTECHNOLOGY is a biotechnology company based in France. It aims at developing novel therapies to treat cancer by targeting cells from the immune system. Its …See details»
Alderaan Biotechnology Reviews, Funding, Founder, Valuation
ALDERAAN BIOTECHNOLOGY is a biotechnology company based in France. It aims at developing novel therapies to treat cancer by targeting cells from the immune system. Its …See details»
Alderaan Biotechnology SAS. (1/9/20). "Press Release: Alderaan ...
Alderaan Biotechnology is a preclinical stage company focused on monoclonal antibodies development for the treatment of cancer with technologies aiming at Treg depletion and NK …See details»
200109_Alderaan Biotechnology funding_EN - adbio.partners
Paris, France, January 9, 2020 – Alderaan Biotechnology, a preclinical stage company focused on monoclonal antibodies development for the treatment of cancer, announces today the …See details»
Alderaan Biotechnology - Contacts, Employees, Board Members, …
Organization. Alderaan Biotechnology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. About. …See details»
Alderaan Biotechnology Raises €19M to Develop Cancer …
Jan 9, 2020 Alderaan, whose name was inspired by a fictional planet in the Star Wars movies, will use part of the money to advance its lead cancer immunotherapy into phase I testing. The …See details»
Alderaan Biotechnology to present results of cancer treatment
Nov 3, 2022 Results of a cancer treatment in the treatment of gynecologic and breast cancer are to be presented next week, November 8-12, at the Society for Immunotherapy of Cancer …See details»
Alderaan Biotechnology presents latest developments in next …
Nov 2, 2022 Alderaan Biotechnology has been developing ALD2150, a low-fucose IL-2-sparing anti-CD25 antibody designed for the selective depletion of Treg; boosting the immune effector …See details»
Series A - Alderaan Biotechnology - 2020-01-09 - Crunchbase
Jan 9, 2020 Alderaan Biotechnology raised $20552290 on 2020-01-09 in Series A. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
Inside the futuristic biotech startup Cellares that’s building a cure ...
3 days ago Inside the futuristic biotech startup Cellares that’s building a cure for cancer with $355 million in fundingSee details»